End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
282 TWD | -2.76% | -11.04% | +3.68% |
Sales 2024 * | 18.82B 580M | Sales 2025 * | 21.2B 654M | Capitalization | 74.58B 2.3B |
---|---|---|---|---|---|
Net income 2024 * | 4.84B 149M | Net income 2025 * | 6.2B 191M | EV / Sales 2024 * | 4.27 x |
Net Debt 2024 * | 5.71B 176M | Net Debt 2025 * | 1.56B 48.2M | EV / Sales 2025 * | 3.59 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
12.5
x | Employees | 1,099 |
Yield 2024 * |
1.9% | Yield 2025 * |
2.66% | Free-Float | 48.47% |
Latest transcript on Lotus Pharmaceutical Co., Ltd.
1 day | -2.76% | ||
1 week | -11.04% | ||
Current month | -12.69% | ||
1 month | -12.69% | ||
3 months | +2.36% | ||
6 months | +19.49% | ||
Current year | +3.68% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-09-28 | |
I ling Tian
DFI | Director of Finance/CFO | - | 16-10-31 |
Ying Ming Yue
COO | Chief Operating Officer | - | 22-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 54 | 15-04-22 |
Director/Board Member | 60 | 14-08-10 | |
Director/Board Member | 61 | 15-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +4.02% | - | |
0.00% | 0 M€ | +3.48% | - | |
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 282 | -2.76% | 4,530,174 |
24-05-08 | 290 | +1.58% | 4,027,227 |
24-05-07 | 285.5 | -4.83% | 10,082,560 |
24-05-06 | 300 | -2.44% | 4,912,211 |
24-05-03 | 307.5 | -3.00% | 5,267,458 |
End-of-day quote Taiwan S.E., May 08, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.68% | 2.3B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- 1795 Stock